Biomarker for predicting disease recurrence in non-metastatic papillary kidney cancer
A biomarker is a biological molecule found in blood, other [...]
Genetic biomarkers for the survival of kidney cancer patients
Previously, researchers found some genes that helped identify which patients [...]
Liquid biomarkers in advanced kidney cancer
In a presentation at the 19th Meeting of the European [...]
PARP1 as a potential biomarker for response to immunotherapy
In a recent study, the researchers looked at the RNA [...]
Blood test that detects 50 types of cancer
A simple blood test that can detect more than 50 [...]
EIKCS 2021: Biomarkers for kidney cancer
Dr Thomas Powles from St Barts Hospital, London spoke about [...]
EIKCS 2021: Combination therapies for metastatic kidney cancer: Which Approach?
The use of combination therapies for the first-line treatment of [...]
Potential biomarker to predict risk of recurrence after nephrectomy for locally advanced kidney cancer
Currently, the search for a reliable biomarker to identify those [...]
IKCS 2020: Treatment selection in kidney cancer
During this interview, Dr Rana McKay from the University of [...]
Individualising first line treatment for advanced kidney cancer
In recent years, a number of new, effective treatments have [...]
